Everence Capital Management Inc. purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 1,431 shares of the medical equipment provider’s stock, valued at approximately $318,000.

Other institutional investors have also modified their holdings of the company. State Street Corp raised its position in shares of Align Technology by 32.2% during the 2nd quarter. State Street Corp now owns 3,143,095 shares of the medical equipment provider’s stock valued at $471,823,000 after purchasing an additional 765,189 shares during the period. Atlantic Trust Group LLC raised its position in shares of Align Technology by 4,682.8% during the 3rd quarter. Atlantic Trust Group LLC now owns 638,935 shares of the medical equipment provider’s stock valued at $119,014,000 after purchasing an additional 625,576 shares during the period. Janus Henderson Group PLC raised its position in shares of Align Technology by 200.5% during the 2nd quarter. Janus Henderson Group PLC now owns 594,124 shares of the medical equipment provider’s stock valued at $89,190,000 after purchasing an additional 396,426 shares during the period. Legal & General Group Plc raised its position in shares of Align Technology by 221.0% during the 3rd quarter. Legal & General Group Plc now owns 383,295 shares of the medical equipment provider’s stock valued at $71,396,000 after purchasing an additional 263,875 shares during the period. Finally, Axiom International Investors LLC DE bought a new stake in shares of Align Technology during the 3rd quarter valued at $27,525,000. Institutional investors and hedge funds own 82.50% of the company’s stock.

In other Align Technology news, VP Julie Tay sold 3,500 shares of the business’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $253.00, for a total value of $885,500.00. Following the completion of the sale, the vice president now directly owns 12,213 shares of the company’s stock, valued at approximately $3,089,889. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Emory Wright sold 45,780 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $260.08, for a total transaction of $11,906,462.40. Following the completion of the sale, the vice president now directly owns 29,957 shares of the company’s stock, valued at $7,791,216.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 85,529 shares of company stock valued at $22,254,743. 1.60% of the stock is owned by corporate insiders.

Align Technology, Inc. (NASDAQ ALGN) opened at $234.33 on Thursday. Align Technology, Inc. has a 52 week low of $92.61 and a 52 week high of $287.32. The company has a market cap of $19,358.90, a PE ratio of 82.51, a P/E/G ratio of 1.84 and a beta of 1.48.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Tuesday, January 30th. The medical equipment provider reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The firm had revenue of $421.30 million during the quarter, compared to analysts’ expectations of $395.88 million. Align Technology had a net margin of 15.71% and a return on equity of 28.55%. The firm’s revenue for the quarter was up 43.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.59 EPS. analysts predict that Align Technology, Inc. will post 4.49 EPS for the current year.

ALGN has been the topic of a number of research reports. Deutsche Bank initiated coverage on shares of Align Technology in a report on Friday, December 8th. They issued a “hold” rating and a $250.00 price target on the stock. Zacks Investment Research downgraded shares of Align Technology from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 27th. Morgan Stanley lifted their price target on shares of Align Technology from $257.00 to $300.00 and gave the company an “overweight” rating in a report on Monday, November 27th. Leerink Swann reiterated an “outperform” rating and issued a $250.00 price target on shares of Align Technology in a report on Friday, October 27th. Finally, Credit Suisse Group lifted their price target on shares of Align Technology from $175.00 to $209.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $258.54.

COPYRIGHT VIOLATION WARNING: “Everence Capital Management Inc. Purchases New Position in Align Technology, Inc. (ALGN)” was originally reported by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.dailypolitical.com/2018/02/08/everence-capital-management-inc-purchases-new-position-in-align-technology-inc-algn.html.

Align Technology Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.